Literature DB >> 10146901

Benefits versus profits: has the orphan drug act gone too far?

A M Garber.   

Abstract

Mesh:

Year:  1994        PMID: 10146901     DOI: 10.2165/00019053-199405020-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  3 in total

1.  Cost of innovation in the pharmaceutical industry.

Authors:  J A DiMasi; R W Hansen; H G Grabowski; L Lasagna
Journal:  J Health Econ       Date:  1991-07       Impact factor: 3.883

2.  The Orphan Drug Act. The first 7 years.

Authors:  C H Asbury
Journal:  JAMA       Date:  1991-02-20       Impact factor: 56.272

3.  Health care and the United States economic system. An essay in abnormal physiology.

Authors:  V R Fuchs
Journal:  Milbank Mem Fund Q       Date:  1972-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.